The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease

Aim of investigation. To estimate the effect of carriage of various allelic variants of blood coagulation system and platelet receptors genes on Wilson’s disease (WD) clinical presentation features. Material and methods. Original study included 85 patients with a Wilson’s disease who were divided in...

Full description

Saved in:
Bibliographic Details
Main Authors: T. P. Rozina, S. V. Fastovets, E. E. Starostina, L. M. Samokhodskaya, T. N. Krasnova
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/229
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860312698257408
author T. P. Rozina
S. V. Fastovets
E. E. Starostina
L. M. Samokhodskaya
T. N. Krasnova
author_facet T. P. Rozina
S. V. Fastovets
E. E. Starostina
L. M. Samokhodskaya
T. N. Krasnova
author_sort T. P. Rozina
collection DOAJ
description Aim of investigation. To estimate the effect of carriage of various allelic variants of blood coagulation system and platelet receptors genes on Wilson’s disease (WD) clinical presentation features. Material and methods. Original study included 85 patients with a Wilson’s disease who were divided into two groups: without neurological symptoms (abdominal form; n=51) and with neurologic symptomatology (mixed form; n=34). Genetic polymorphism testing was carried out by real-time polymerase chain reaction with melting curve analysis. Results. Alleles A of hemostasis genes FII 20210 G/A, FV 1691G/A were more frequent in the group with neurologic symptomatology as compared to the group of patients with abdominal form of WD at the level of trend. Frequency of 5G allele of plasminogen activator inhibitor gene PAI-675 5G/4G in the group with neurologic symptoms was lower (41.17%), than in the group without symptoms of central nervous system (CNS) involvement (49.02%) (odds ratio - OR: 1.374; 95% confidence interval - CI: 0.739-2.553). In the group of patients with neurological symptoms 4G4G genotype of PAI-675 5G/4G gene was more common (47.06%), than in patients without those symptoms (23.53%) (OR: 2.889; 95%-CI: 1.135-7.350). The allele T of platelet receptor gene ITGA2 807 C/T was more common in patients with CNS involvement than in the group of patients without neurological symptoms (р =0.018; OR: 2.172. 95%-CI: 1.163-4.058). Integrated genotype CT+TT was significantly more common in patients with neurological symptoms (82.35%) as compared to patients without those (54.90%) (р =0.010; OR: 3,833; 95%-CI: 1.355-10.846). Conclusion. Carriage of mutant genotypes FII 20210 G/A, FV 1691G/A, PAI-675 5G/4G, ITGA2 807 C/T is the factor associated to the presence of neurological symptoms at Wilson's disease.
format Article
id doaj-art-dba1d8d02b154fe39d7f36d66759592c
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-dba1d8d02b154fe39d7f36d66759592c2025-02-10T16:14:29ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01282505510.22416/1382-4376-2018-28-2-50-55229The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s diseaseT. P. Rozina0S. V. Fastovets1E. E. Starostina2L. M. Samokhodskaya3T. N. Krasnova4ГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»; ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» (Сеченовский университет)ГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»ГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»ГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»ГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»Aim of investigation. To estimate the effect of carriage of various allelic variants of blood coagulation system and platelet receptors genes on Wilson’s disease (WD) clinical presentation features. Material and methods. Original study included 85 patients with a Wilson’s disease who were divided into two groups: without neurological symptoms (abdominal form; n=51) and with neurologic symptomatology (mixed form; n=34). Genetic polymorphism testing was carried out by real-time polymerase chain reaction with melting curve analysis. Results. Alleles A of hemostasis genes FII 20210 G/A, FV 1691G/A were more frequent in the group with neurologic symptomatology as compared to the group of patients with abdominal form of WD at the level of trend. Frequency of 5G allele of plasminogen activator inhibitor gene PAI-675 5G/4G in the group with neurologic symptoms was lower (41.17%), than in the group without symptoms of central nervous system (CNS) involvement (49.02%) (odds ratio - OR: 1.374; 95% confidence interval - CI: 0.739-2.553). In the group of patients with neurological symptoms 4G4G genotype of PAI-675 5G/4G gene was more common (47.06%), than in patients without those symptoms (23.53%) (OR: 2.889; 95%-CI: 1.135-7.350). The allele T of platelet receptor gene ITGA2 807 C/T was more common in patients with CNS involvement than in the group of patients without neurological symptoms (р =0.018; OR: 2.172. 95%-CI: 1.163-4.058). Integrated genotype CT+TT was significantly more common in patients with neurological symptoms (82.35%) as compared to patients without those (54.90%) (р =0.010; OR: 3,833; 95%-CI: 1.355-10.846). Conclusion. Carriage of mutant genotypes FII 20210 G/A, FV 1691G/A, PAI-675 5G/4G, ITGA2 807 C/T is the factor associated to the presence of neurological symptoms at Wilson's disease.https://www.gastro-j.ru/jour/article/view/229болезнь вильсона-коноваловаполиморфизм геновтромбофилиягемостазтромбоцитарные рецепторы
spellingShingle T. P. Rozina
S. V. Fastovets
E. E. Starostina
L. M. Samokhodskaya
T. N. Krasnova
The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
болезнь вильсона-коновалова
полиморфизм генов
тромбофилия
гемостаз
тромбоцитарные рецепторы
title The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
title_full The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
title_fullStr The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
title_full_unstemmed The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
title_short The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
title_sort clinical role of blood coagulation and platelet receptors gene allelic variants in development of wilson s disease
topic болезнь вильсона-коновалова
полиморфизм генов
тромбофилия
гемостаз
тромбоцитарные рецепторы
url https://www.gastro-j.ru/jour/article/view/229
work_keys_str_mv AT tprozina theclinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT svfastovets theclinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT eestarostina theclinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT lmsamokhodskaya theclinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT tnkrasnova theclinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT tprozina clinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT svfastovets clinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT eestarostina clinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT lmsamokhodskaya clinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease
AT tnkrasnova clinicalroleofbloodcoagulationandplateletreceptorsgeneallelicvariantsindevelopmentofwilsonsdisease